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Background: Over the years, frozen elephant trunk (FET) has become the treatment of choice for 
multisegmental thoracic aortic disease. This multicenter study presents the evolution of FET results using 
the E-vita Open hybrid graft with respect to institutional experience and time.
Methods: The data of International E-vita Open registry were studied according to the institutional 
experience of the participating centers (high- versus low-volume centers) and according to the evolution of 
FET treatment during time (1st period, 2005–2011 versus 2nd period, 2012–2018). Overall, 1,165 patients 
were enrolled in the study with a wide variety of multisegmental thoracic aortic pathologies and aortic 
emergencies. Participating centers determined their own surgical protocol.
Results: The overall 30-day mortality was 12%. Short- and long-term survival were higher in high- versus 
low-volume centers (P=0.048 and P=0.013, respectively). In the 2nd time period, cerebral complications were 
reduced significantly (P=0.015). Incidence of permanent spinal cord-related symptoms was reduced to 3% in 
the 2nd time period, but did not reach statistical significance. Hypothermic circulatory arrest time (P<0.001) 
and incidence of postoperative temporary renal replacement therapy (P=0.008) were significantly reduced in 
the 2nd time period. Ten-year survival and freedom from aortic-related death rates were 46.6% and 85.7%, 
respectively, for the entire group. The freedom from distal aortic re-interventions for a new or progressive 
residual aortic disease was 76.0%.
Conclusions: Evolution of FET arch repair techniques with the E-vita Open graft and increasing 
institutional experience were associated with improved results. Progression of residual aortic disease makes 
close follow-up with aortic imaging mandatory in such patients.
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Introduction
Aortic arch disease (i.e., aneurysm or dissection) is 
commonly combined with additional pathology of the 
descending aorta. In this setting, the frozen elephant 
trunk (FET) technique offers the option for a combined 
treatment of the aortic arch and the descending aorta in 
one step (1). It is based on the use of a hybrid graft, which 
enables the surgical replacement of the aortic arch and the 
endovascular exclusion of the descending aortic disease via a 
single median sternotomy. Although this surgical approach 
is considered a major surgery with substantial morbidity 
and mortality, FET currently represents the treatment of 
choice in many institutions. The hybrid graft can be applied 
in a wide variety of aortic arch pathologies with very few 
restrictions regarding aortic arch anatomy, including aortic 
emergencies (2-5).
In Europe, the first serial experience with FET 
technique was started in 2005 using the E-vita Open™ 
hybrid graft (Jotec/CryoLife, Kennesaw, GA, USA), the 
first commercially available FET prosthesis (6). Several 
lessons were learned during the early experience including 
patient selection, graft sizing and deployment, as well as 
improved organ protection techniques (7). The aim of this 
multicenter study was to evaluate the influence of increased 
institutional experience with FET treatment, as well as the 
effect of time, on postoperative results.
Methods
Data were recorded anonymously among participating 
centers in the database of the International E-vita Open 
registry and were evaluated for completion. Centers 
with incomplete documentation were excluded from the 
statistical analysis. Between 2005 and 2018, 19 European 
centers provided complete data on 1,165 patients, which 
form the basis of this study. The indications for surgery 
were acute or chronic type A, non-A-non-B, and type B 
aortic dissection, as well as degenerative aneurysmal disease 
of the distal arch or thoracoabdominal aorta. All patients 
underwent FET surgery with the E-vita Open™ and from 
2009 onwards with the next generation of the graft, the 
E-vita Open Plus™.
In order to evaluate the hospital experience of FET 
technique, referring centers that performed more than fifty 
FET operations or more than ten patients per year, were 
considered high-volume centers. Six centers were classified 
as high-volume and thirteen as low-volume. In an attempt 
to differentiate and capture the learning experience, data 
were also divided into two key time intervals: period 1 from 
2005–2011 and period 2 from 2012–2018.
Participating centers determined their own surgical 
protocol, including cannulation technique, temperature 
management, circulatory arrest technique, perfusion 
management, myocardial protection, graft sizing, and 
arch repair technique (e.g., en bloc versus separate branch 
reimplantation, debranching of the left subclavian, etc.). 
More detailed descriptions of these techniques can be found 
in previous publications (8-10). All patients in the current 
study underwent open arch repair via median sternotomy 
under hypothermic circulatory arrest and selective cerebral 
perfusion. Decision of graft sizing and planning of surgery 
for one- or two-staged procedures were performed by the 
referral centers.
E-vita Open and E-vita Open Plus
The E-vita Open and the E-vita Open Plus graft consists 
of two vascular prosthetic components as a continuous 
tube: a proximal surgical prosthesis for the arch and a 
distal self-expandable stent graft with Z-nitinol stents for 
the descending aorta. The graft is delivered by a flexible 
atraumatic introducer through the open aortic arch into 
the lumen of the descending aorta, and is deployed with 
the proximal arch graft crimped and invaginated within the 
stent graft lumen (6). This design enables the fixation of 
the graft in the aortic arch level by surgical suture, similar 
to the modified elephant trunk technique (11). After suture 
fixation, the incorporated arch prosthesis is released from 
the stent graft lumen into the arch position and is used for 
the replacement of the arch. In E-vita Open Plus, a collar 
has been added between the two components of the graft 
in order to facilitate suture fixation to the aortic wall. The 
tubular form of the prosthesis allows the implantation of 
the supra-aortic arteries en-bloc, as well as separately with or 
without interposition grafts. The E-vita Open stent graft 
diameters are available between 20 and 40 mm, and the 
stent graft length is between 130 and 160 mm.
Definitions
Over time, the technique of arch repair was changed in 
most participating centers, with debranching techniques 
for rerouting of the left subclavian artery in order to 
proximalize the stent graft fixation to zone 2 or even more 
proximally. In order to simplify the presentation of the arch 
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arteries revascularization technique, a common reinsertion 
of the brachiocephalic trunk and the left carotid artery 
was called “en-bloc” technique. “Separate reimplantation” 
technique represents only those patients with separate 
reinsertion of all three arch arteries, directly or by 
interposition grafts.
Mortality is presented as 30-day mortality or in-hospital 
mortality. Stroke is reported as a new permanent cerebral 
event, or a temporary event in case of neurological recovery. 
Spinal cord ischemic injury includes both paraplegia and 
paraparesis, and is presented as a permanent event in case 
of persisting neurological deficit. Spinal cord events with 
regressive neurological symptoms up to complete recovery 
were defined as temporary.
Statistical analysis
Data analysis was performed with the SPSS Package 26. 
Categorical and continuous variables are presented in 
percent and mean ± standard deviation (SD), respectively. 
The two-sided Fischer exact test or the independent 
Student’s t-test, if appropriate, were used for calculation of 
statistical significance (P<0.05) between groups.
Follow-up was provided by the referral centers 
for 989 patients at a mean ± SD time of 3.2±2.8 years 
postoperatively. Estimated calculations of survival and 
freedom from re-interventions in follow-up were performed 
by the Kaplan-Meier analysis. Cox regression analysis 
was used to evaluate the impact of centers and learning 
experience to survival and the freedom of aortic re-
interventions. According to the number of patients available 
at follow-up, the statistical analysis for differences between 
groups was performed at 6 years. Aortic-related death 
within follow-up was defined as a death related to proximal 
or distal aortic disease, secondary aortic treatment, and 
unknown cause of death.
Results
Patient characteristics
The average age of patients was 61.6±12 years and 67.5% 
were male (Table 1). In high-volume centers, more patients 
underwent surgery for acute aortic dissection (P<0.001) 
and they suffered from more comorbidities including aortic 
valve regurgitation (P=0.002), renal insufficiency (P=0.003) 




Centers volume Study periods
Low (N=334) High (N=831) P First (N=385) Second (N=780) P
Age 61.6±12 63.1±12 61.0±12 0.007 61.4±12 61.7±12 0.664
Male 786 [68] 208 [62]  578 [70] 0.019 275 [71] 511 [66] 0.046
Aortic disease
Acute dissection 444 [38] 88 [26] 356 [43] <0.001 134 [35] 310 [40] 0.109
Chronic dissection 329 [28] 98 [29] 231 [28] 0.615 125 [32] 204 [26] 0.027
Aneurysm 392 [34] 148 [44] 244 [29] <0.001 126 [33] 266 [34] 0.693
Coronary artery disease 209 [18] 49 [15] 160 [19] 0.076 64 [17] 145 [19] 0.465
Aortic valve regurgitation ≥ II° 437 [38] 102 [31] 335 [40] 0.002 129 [34] 308 [40] 0.054
Previous sternotomy 278 [24] 88 [26] 190 [23] 0.224 113 [29] 165 [21] 0.003
Previous endo- treatment 68 [6] 18 [5] 50 [6] 0.783 24 [6] 44 [6] 0.691
Renal insufficiency 91 [8] 14 [4] 77 [9] 0.003 37 [10] 54 [7] 0.131
COPD 241 [21] 48 [14] 193 [23] 0.001 62 [16] 179 [23] 0.007
History of stroke 76 [7] 24 [7] 52 [6] 0.600 22 [6] 54 [7] 0.528
Peripheral artery disease 152 [13] 62 [19] 90 [11] 0.001 70 [18] 82 [11] <0.001
Data are presented as n [%]. COPD, chronic obstructive pulmonary disease.
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and pulmonary disease (P=0.001). By contrast, low-volume 
centers had a higher percentage of females (P=0.019), 
degenerative aortic disease (P<0.001), and concomitant 
peripheral artery disease (P<0.001). With respect to the 
time period of the study, a significantly increased number 
of chronic aortic dissection patients (P=0.027) and re-
do surgeries (P=0.003) were recorded during the 1st time 
period.
Intraoperative results
Right axillary artery cannulation (69.6%) and bilateral 
selective cerebral perfusion (94.0%) were performed in the 
majority of patients and more often in high-volume centers 
(P=0.048 and P=0.004, respectively, Table 2). Femoral 
artery cannulation (3.4%) was more frequent in low-
volume centers (P=0.031). Patients in high-volume centers 
more commonly underwent en-bloc reimplantation of the 
brachiocephalic trunk and left carotid artery (P<0.001), 
as well as a valve-sparing aortic root repair (P<0.001) and 
concomitant coronary artery revascularization (P=0.042). 
Duration of cardiopulmonary bypass (CPB) (P=0.004), 
cardioplegic arrest (P=0.002), selective antegrade cerebral 
perfusion (SACP) (P<0.001) and intraoperative visceral 
ischemia (P<0.001) were significantly lower in high- versus 
low-volume centers.




Centers volume Study periods
Low (N=334) High (N=831) P First (N=385) Second (N=780) P
Artery access
Axillary artery 811 [70] 218 [65] 593 [71] 0.048 248 [64] 563 [72] 0.008
Proximal aorta 165 [14] 55 [17] 110 [13] 0.164 85 [22] 80 [10] <0.001
Femoral artery 40 [3] 18 [5] 22 [3] 0.031 16 [4] 24 [3] 0.392
Other 152 [13] 44 [13] 108 [13] 0.924 37 [10] 115 [15] 0.016
Selective cerebral perfusion 0.004 0.004
Bilateral 1,095 [94] 303 [91] 792 [95] 373 [97] 722 [93]
Unilateral 70 [6] 31 [9] 39 [5] 12 [3] 58 [7]
Arch arteries reimplantation <0.001 0.068
En-bloc 756 [65] 189 [57] 567 [68] 264 [69] 492 [63]
Separately 409 [35] 145 [43] 264 [32] 121 [31] 288 [37]
Ascending aortic replacement 1,023 [88] 299 [90] 724 [87] 0.277 303 [79] 720 [92] <0.001
Root replacement
Bentall 157 [14] 52 [16] 105 [13] 0.185 46 [12] 111 [14] 0.316
David, Yacoub 153 [13] 12 [4] 141 [17] <0.001 30 [8] 123 [16] <0.001
Aortic valve replacement 78 [7] 21 [6] 57 [7] 0.796 30 [8] 48 [6] 0.319
CABG 161 [14] 28 [8] 133 [16] <0.001 60 [16] 101 [13] 0.241
Operative times, minutes
CPB 234±72 244±87 230±65 0.004 238±73 232±72 0.217
Cross clamp 138±55 146±70 135±47 0.002 138±51 138±57 0.942
SACP 72±37 89±55 65±24 <0.001 73±29 72±40 0.655
Visceral ischemia 58±27 65±31 55±24 <0.001 66±26 54±26 <0.001
Data are presented as n [%]. CPB, cardiopulmonary bypass; SACP, selective antegrade cerebral perfusion.
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In the 2nd time period, the number of right axillary artery 
cannulation increased in comparison to the 1st time period 
(P=0.008). In addition, the number of direct cannulation 
of the proximal aorta decreased significantly (P<0.001) 
and the number of other cannulation techniques (e.g., 
brachiocephalic trunk, carotid artery) increased (P=0.016). 
In 2nd time period, bilateral selective cerebral perfusion 
remained the most frequent technique for cerebral 
protection. Proximally, more ascending aorta interventions 
(P<0.001) and aortic valve sparing procedures (P<0.001) 
were performed in the 2nd time period. With regard to 
intraoperative times, visceral ischemia time decreased 
significantly in the 2nd time period (P<0.001).
Postoperative results
Thirty-day mortality was significantly lower in high-volume 
centers (11.0% vs. 15.3%, P=0.048), as was in-hospital 
mortality (13.7% vs. 18.6%, P=0.046, Table 3). The total 
incidence of cerebral (7.1%) and spinal cord complications 
(6.6%) was statistically similar in both groups. Of these, 
permanent cerebral and spinal cord complications occurred 
in 5.2% and 3.9%, respectively. In high- versus low-volume 
centers, the incidence of postoperative cardiac failure (9.0% 
vs. 14.1%, P=0.015) and re-exploration for bleeding (11.7% 
vs. 16.2%, P=0.043) was significantly lower in high-volume 
centers. Other postoperative complications including renal, 
pulmonary, visceral and peripheral complications were 
statistically similar in both groups.
In the 2nd versus 1st time period, 30-day mortality (12% 
vs. 13%, P=0.447) and in-hospital mortality (14% vs. 17%, 
P=0.258) were statistically similar. Cerebral complications 
decreased significantly in the 2nd time period (5.8% vs. 
9.9%, P=0.015). In addition, the incidence of permanent 
(3.2%) and temporary (3.1%) spinal cord ischemia-related 
symptoms was numerically lower in the 2nd time period, 
but not significantly. The incidence of postoperative renal 
replacement therapy (19.4%) decreased significantly in the 
2nd time period (P=0.008).
The estimated 10-year overall survival for the entire 
group of patients was 46.6% (Figure 1A,B,C,D). At 
6 years, survival was poorer in low-volume (56.1%) vs. high-
volume (63.3%) centers (HR, 1.332; 95% CI, 1.060–1.675; 
P=0.014), Figure 2A, and was statistically similar between 
Table 3 Postoperative data
Patients Overall (N=1,165)
Centers volume Study periods
Low (N=334) High (N=831) P First (N=385) Second (N=780) P
Mortality
30 days 142 [12] 51 [15] 91 [11] 0.048 51 [13] 91 [12] 0.447
In-hospital 176 [15] 62 [19] 114 [14] 0.046 65 [17] 111 [14] 0.258
Stroke 83 [7] 22 [7] 61 [7] 0.707 38 [10] 45 [6] 0.015
Permanent 61 [5] 13 [4] 48 [6] 0.244 25 [7] 36 [5] 0.208
Temporary 34 [3] 13 [4] 21 [2] 0.247 14 [4] 20 [3] 0.355
Spinal cord ischemia 77 [7] 24 [7] 53 [6] 0.604 32 [8] 45 [6] 0.104
Permanent 46 [4] 12 [4] 34 [4] 0.868 21 [6] 25 [3] 0.078
Temporary 38 [3] 14 [4] 24 [3] 0.275 14 [4] 24 [3] 0.603
Cardiac low output 122 [11] 47 [14] 75 [9] 0.015 47 [12] 75 [10] 0.186
Respiratory insufficiency 329 [28] 82 [25] 247 [30] 0.084 102 [27] 227 [29] 0.369
Renal replacement therapy 252 [22] 61 [18] 191 [23] 0.083 101 [26] 151 [19] 0.008
Visceral organs 33 [3] 10 [3] 23 [3] 0.846 13 [3] 20 [3] 0.455
Peripheral ischemia 35 [3] 12 [4] 23 [3] 0.452 15 [4] 20 [3] 0.208
Re-exploration for bleeding 151 [13] 54 [16] 97 [12] 0.043 55 [14] 96 [12] 0.355
Data are presented as n [%].
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Figure 1 Kaplan-Meier analysis for overall cumulative survival (A), freedom from aortic related death (B) and freedom from proximal 
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the 1st (60.6%) and 2nd (66.5%) time periods (HR, 1.154; 
95% CI, 0.924–1.1442; P=0.206), Figure 2B. During follow-
up, 46 patients (4.6%) succumbed to a verified proximal or 
distal aortic-related complication, and in 19 (1.9%) patients 
the cause of death was unknown. The overall freedom 
from aortic-related death at 10 years was therefore 85.7% 
(Figure 1B). The freedom from aortic-related death at 6 
years was similar in high-volume (90.5%) vs. low-volume 
(92.5%) centers (HR, 1.058; 95% CI, 0.579–1.936; 
P=0.854), as well as in the 1st (91.0%) and 2nd (91.3%) 
periods (HR, 0.935; 95% CI, 0.546–1.600; P=0.806).
Postoperatively,  207 (17.8%) of 1,165 patients 
underwent at least one secondary intervention; 24 (2.1%) 
in the proximal aorta and 182 (15.6%) in the downstream 
aorta. Indication for proximal aortic surgery was aortic 
valve regurgitation in 13 (1.1%), infectious endocarditis 
in 7 (0.6%) and aortic root false aneurysm in 4 (0.3%). 
Re-interventions in the distal aorta were performed by 
open surgery in 59 (5%) and/or endovascular surgery in 
130 (11.2%). In 70 of 182 (6.0%) patients, the distal re-
intervention followed as a second procedure of a planned 
two-staged treatment. Of the other 112 patients, 90 
(7.7%) underwent a second intervention for a progressive 
residual aortic pathology and 22 (1.9%) for a new aortic 
finding including distal stent graft-induced new entries and 
endoleaks, aortic rupture, and aortic fistula. At 10 years, 
the overall freedom from aortic re-intervention was 63.2% 
(Figure 1C) and the freedom from aortic re-interventions 
downstream for progressive or new aortic findings was 
76.0% (Figure 1D). Freedom from re-interventions was 
statistically similar between high- versus low-volume 
centers and between the 1st and 2nd time periods of the study 
(Figure 2C,D,E,F).
Discussion
The FET technique enables the extension of the aortic arch 
treatment into the descending aorta by implementation of 
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Figure 2 Cumulative survival and freedom from re-interventions at 6 years follow-up between the high- versus low-volume centers (A,C) 
and between the 1st and 2nd period of the study (B,D); the freedom from re-interventions along the descending aorta distal to the graft is 
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an endovascular stent graft to a classic surgical prosthesis. 
FET can be applied to almost all multisegmental thoracic 
aortic pathologies, with the exception of descending 
aortic free rupture, mycotic aneurysms, and severe aortic 
isthmus stenosis (2). Besides the option to treat a distally 
extended aortic arch disease in one stage via a single 
median sternotomy, FET allows the durable exclusion of 
the proximal segment of an otherwise extensive thoracic/
thoracoabdominal aortic disease. FET also facilitates a 
second endovascular aortic treatment downstream with 
the covered stent component of the FET prosthesis, 
representing a safe and reliable proximal landing zone for 
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TEVAR (12). Furthermore, the deployment of FET in the 
mid descending aortic segment facilitates a second open 
thoracoabdominal approach, since aortic clamping can be 
positioned at the easily accessible proximal descending aorta 
and far away from the more complicated transition zone of 
the distal aortic arch (13).
In acute aortic dissection, the FET stent graft supports 
the true lumen and the surgical anastomosis from inside, 
improving hemostasis and reducing late anastomosis-
related complications like pseudoaneurysms and new 
distal anastomotic entry sites. The false lumen exclusion 
in aortic dissection by the stent graft results in positive 
remodeling and resorption of the false lumen thrombus 
proximally, as well as stabilization of the true lumen distally, 
in the majority of patients (14,15). This effect is similar 
to endovascular stent graft therapy after exclusion of the 
primary proximal entry tear in the descending aorta (16,17). 
However, in case of FET and in contrary to the classic 
endovascular treatment, this positive aortic remodeling is 
achieved without the otherwise required oversizing of the 
stent graft (7). In addition, a circumferential running suture 
fixes the FET-stent graft permanently, so that the risk of 
stent graft migration and proximal endoleak is minimized. 
Furthermore, this surgical fixation enables the deployment 
of the stent graft in each part of the aortic arch without the 
prerequisite of a suitable proximal landing zone, as in classic 
endovascular treatment. Thus, FET can be used not only 
in acute type A aortic dissection, but also in non-A-non-B 
as well as type B aortic dissections with a limited proximal 
landing zone for TEVAR therapy (18,19).
Although the advantages of FET for the treatment of 
multisegmental thoracic aortic disease are well known, the 
use of FET as standard treatment for such patients remains 
controversial (20,21). FET is a major invasive operation 
and is associated with substantial morbidity and mortality. 
The treatment requires the use of extracorporeal circulation 
and hypothermic circulatory arrest, and the duration of 
surgery is prolonged. Thus, proper patient selection is 
mandatory. In particular, frail patients or patients with 
multiple comorbidities, such as severe pulmonary lung 
disease and generalized peripheral atherosclerotic disease, 
are associated with an increased mortality risk (22,23). In 
addition, the experience of surgeons and institutions in 
dealing with complex aortic arch and descending aorta 
pathologies, as well as aortic emergencies, may influence 
postoperative outcomes. Thus, the first aim of the study 
was the evaluation of patients’ outcomes after FET surgery 
in association with the institutional FET experience. 
The second aim of the study was the evaluation of results 
according to longitudinal increasing experience with FET 
over time.
The first commercially available FET-prosthesis was 
the E-vita Open, which was introduced in 2005. The 
observation of an increased risk of major complications, 
such as spinal cord ischemia, led to the evolution of surgical 
techniques in order to reduce surgical trauma, to improve 
distal organ protection, and to increase the safety of FET 
deployment (24). In addition, observations about the fate 
of the residual descending aorta disease after FET have 
enabled a safer estimation of proper graft sizing for these 
operations. In order to achieve both of the above-mentioned 
objectives, data from the International E-vita Open registry 
were analyzed according to the frequency and number of 
FET procedures performed in participating centers, as well 
as comparisons between the first and second periods of the 
study.
Our results demonstrate significant differences 
between low- and high-volume centers with regard to 
patient selection, concomitant procedures, intraoperative 
techniques, and postoperative outcomes. Low-volume 
centers operated on a higher proportion of patients with 
degenerative aortic aneurysmal disease, and high-volume 
centers operated on more patients with acute aortic 
dissection and aortic regurgitation. A difference in patients’ 
age was therefore noted, with an older average patient age 
in low-volume centers compared to high-volume centers. 
Although the use of FET in acute aortic dissection is 
controversial, our results demonstrate that the frequency 
of FET application in aortic emergencies increases with 
institutional experience. In addition, heterogeneous 
comorbidities were noticed between centers. The increased 
frequency of patients with chronic pulmonary and renal 
disease in high-volume centers also demonstrates the 
tendency to apply FET treatment in patients with a high 
risk for postoperative complications and prolonged intensive 
care treatment. Otherwise, peripheral artery disease was 
more common in low-volume centers and probably related 
to the increased number of patients with degenerative 
aortic disease. Right axillary artery cannulation and bilateral 
selective cerebral perfusion is felt to be the technique of 
choice for perfusion and cerebral protection in open aortic 
arch surgery. However, both techniques were used more 
frequently in high-volume centers. Although the incidence 
of adjunct aortic valve-sparing root repair and coronary 
artery revascularization was significantly increased in high-
volume centers, the operative times were significantly lower. 
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This observation confirms the association between duration 
of surgery and institutional experience with complex aortic 
disease. The positive impact of centers’ experience with 
FET treatment was also demonstrated by the significantly 
decreased 30 day and in-hospital mortality. Treatment 
in low-volume centers was associated with an increased 
number of cardiac complications and re-explorations 
for bleeding. In contrary, the incidence of postoperative 
temporary renal replacement was more common in high-
volume centers. Finally, neurological cerebral and spinal 
cord-related complications were statistically similar in both 
groups.
The chronological analysis demonstrated a shift of 
FET application towards more acute and significantly 
less chronic aortic dissections. The less favorable aortic 
remodeling in chronic dissection and emergence of new 
endovascular techniques for the treatment of a chronic 
dissected aortic arch could be reasons for this observation 
(3,25). However, institutional policies of the centers with 
regard to patient selection and choice of FET graft may 
influence this result. The reduced number of redo-surgeries 
and chronic aortic dissections in 2nd time period explains 
the increased frequency of ascending aorta replacement 
in comparison to the 1st. In the 2nd time period, the 
increased use of unilateral cerebral perfusion and other 
artery cannulation techniques may express a tendency for a 
more patient-tailored approach. With regard to operative 
times, the duration of distal hypothermic circulatory arrest 
distally decreased significantly in the 2nd time period. The 
main cause for this reduction was the implementation of 
distal body selective perfusion during the arch repair in 
some centers. In addition, a significant reduction of renal 
replacement therapy occurred.
The observed mortality rates were similar between 
time periods. However, in the 2nd time period, a significant 
reduction of cerebral complications as well as reduction 
of spinal cord complications was observed. The reduction 
of the E-vita Open stent graft length from 15 to 13 cm 
and the implementation of distal body selective perfusion 
during the study period may have contributed to the 
observed reduction of spinal cord complications (23,25). 
Nowadays, FET surgery can be applied with similar results 
in comparison to classic open aortic arch surgery and with a 
less residual risk for spinal cord complication, close to that 
observed during endovascular stent graft therapy (26,27).
Our study demonstrates improved results of FET 
treatment over time. In addition, increasing experience 
in high-volume centers was associated with an improved 
survival in follow-up. Considering the high-risk patient 
population with aortic emergencies including those with 
extensive aneurysmal disease, our observed mortality 
rate and survival is acceptable. Although endovascular 
technology is working towards zone 0 treatment (28), the 
vast majority of aortic pathologies presented in the current 
study are not yet suitable for endovascular treatment. 
Restrictions such as absent or short proximal landing zones 
in the aneurysmatic and dissected ascending aorta have led 
to slow progress in this regard.
The freedom of aortic-related death in the current study 
was 85%, indicating an ongoing risk of severe complications 
such as aortic rupture and aortic fistula. Considering the 
proximal complications associated with the aortic valve and 
aortic root, compromises in proximal surgical repair due to 
the extension of the aortic arch surgery should be avoided. 
Downstream, new aortic pathologies and progress of the 
residual disease may occur, so close follow-up with repeated 
aortic imaging is strongly recommended.
The results of the International E-vita Open Registry 
demonstrate that FET surgery has improved over the years, 
and with increasing institutional experience. Although 
our study is limited by its retrospective design, it is one of 
the largest studies to date on this procedure. The lack of a 
standardized surgical protocol between centers is another 
potential weakness of the study, but this heterogeneity also 
allows for analysis of “real-world” practice. Our data also 
demonstrate that an institutional learning curve exists and 
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